GSK Archives - DelveInsight

GSK

uncomplicated-urinary-tract-infections-market
Fight Against the Antibiotic Resistance in the Uncomplicated Urinary Tract Infections Market

Uncomplicated Urinary Tract Infections are one of the most commonly diagnosed infections in the US, with the maximum prevalence in women who are sexually active. A wide range of pathogens can be a...


latest-biotech-healthcare-pharma-news-updates-aelis-farma-alcyone-progentec-gsk-kozin
Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collabor...

Aelis Farma pockets USD 30 Million upfront in cannabis use disorder deal with IndiviorIndivior speculates that Aelis Farma has what it takes to bring cannabis use disorder therapy into the cli...


recent-pharma-biotech-healthcare-news-and-updates-for-nih-roche-regeneron-gsk
NIH awards $107M for COVID-19 testing tech; GSK secures rights; Roche’s bispecific matches ...

NIH awards USD 107 Million for radical COVID-19 testing tech The National Institutes of Health (NIH) awarded over USD 107 million for radical approaches to testing for COVID-19 and tracin...


recent-pharma-news-and-updates-for-novartis-gsk-exact-sciences-eqrx
Novartis taps Molecular Partners to combat COVID-19; GSK culls phase 2 asthma drug; Exact Science...

Novartis taps Molecular Partners for a novel approach to combat COVID-19Novartis is spending USD 69 million upfront on a pair of experimental drugs from Molecular Partners.The pact is for ...


Pharma news fro GSK, InCarda, BridgeBio
GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; B...

GSK eyes robust immune response from RSV vaccineCold viruses mostly do not get much attention in terms of R&D. They usually make humans feel miserable for a few days, and later than clear...


recent-Pharma-news-and-happenings
Roche-UCB’s $120M collaboration; Omega snags $85M; ExeVir raises $27M; GSK culls pipeline m...

Roche bets USD 120 Million on UCB's anti-tau Alzheimer's antibodyThe Swiss pharma, Roche, is handing over USD 120 million upfront for the right of UCB's anti-tau antibody development. If every...


Pharma happenings and latest COVID-19 News
AZ shows positive results for its COVID-19 vaccine; Synairgen offers a new approach to address CO...

AstraZeneca demonstrates positive early results from its trial evaluating COVID-19 vaccine-AZD1222In a frenzied race to find a global cure for COVID-19, several pharma players are testing wat...


Covid-19-diagnostic-projects
Potential Diagnostic solutions that may significantly contribute to COVID-19 detection

Novel coronavirus outbreak has created some unprecedented situations in several domains round the World. No vertical is left untouched as the economy tumbles down impacting the human race. Goals o...


pharma news
AstraZeneca targets for COVID-19 antibody trial; Arrakis, Roche team up; GSK, AstraZeneca launch ...

AstraZeneca aims for summer start for COVID-19 antibody trialAstraZeneca has made its multipronged approach to the development of antibodies against the pandemic SARS-CoV-2 virus. The giant is...


pharma news
Immunomedics Halts Sacituzumab govitecan trial; GSK-Vir Biotech collaboration; INO-4800 DNA COVI...

Immunomedics discontinues its trial early – hopes for accelerated approval of Sacituzumab govitecan for mTNBCImmunomedics- a New Jersey-based pharmaceutical company has announced to freeze its...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.